Celldex Therapeutics (CLDX) Amortization - Goodwill (2018)
Celldex Therapeutics has reported Amortization - Goodwill over the past 1 years, most recently at -$24000.0 for Q2 2018.
- Quarterly results put Amortization - Goodwill at -$24000.0 for Q2 2018, changed N/A from a year ago — trailing twelve months through Dec 2018 was $91.0 million (changed N/A YoY), and the annual figure for FY2018 was $91.0 million, changed.
- Amortization - Goodwill for Q2 2018 was -$24000.0 at Celldex Therapeutics, down from $91.0 million in the prior quarter.
- Over the last five years, Amortization - Goodwill for CLDX hit a ceiling of $91.0 million in Q1 2018 and a floor of -$24000.0 in Q2 2018.